Pruritus assessment in clinical trials: Consensus recommendations from the international forum for the study of itch (IFSI) special interest group scoring itch in clinical trials

Acta Dermato-Venereologica

Volumn 93, Issue 5, 2013, Pages 509-514

  Ständer, Sonja ^a   Augustin, Matthias ^b   Reich, Adam ^c   Blome, Christine ^b   Ebata, Toshiya ^d   Phan, Ngoc Quan ^a   Szepietowski, Jacek C ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Data bank; Itch; Patient beneft index; Pruritus; Quality of life; Visual analogue scale

Indexed keywords

ARTICLE; BECK DEPRESSION INVENTORY; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); DERMATOLOGY LIFE QUALITY INDEX; DISEASE COURSE; HAMILTON SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRE; SCRATCHING;

ANTIPRURITICS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; PREDICTIVE VALUE OF TESTS; PRURITUS; QUALITY OF LIFE; QUESTIONNAIRES; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84883472012     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1620     Document Type: Article

References (30)

1. Matterne U, Apfelbacher CJ, Loerbroks A, Schwarzer T, Büttner M, Ofenloch R, et al. Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study. Acta Derm Venereol 2011; 91: 674-679.
2. Ständer S, Weisshaar E, Mettang T, Szepietowski JC, Carstens E, Ikoma A, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch. Acta Derm Venereol 2007; 87: 291-294.
3. Szepietowski JC, Reich A, Wiśnicka B. Itching in patients suffering from psoriasis. Acta Dermatovenerol Croat 2002; 10: 221-226.
4. Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92: 502-507.
5. Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497-501.
6. Furue M, Ebata T, Ikoma A, Takeuchi S, Kataoka Y, Takamori K, et al. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Ve -nereol 2013; 93: 214-221.
7. Ständer S, Blome C, Breil B, Bruland P, Darsow U, Dugas M, et al. Erfassung von Pruritus - aktuelle Standards und Implikationen für die Praxis. Hautarzt 2012; 63: 521-531.
8. Blome C, Augustin M, Siepmann D, Phan NQ, Rustenbach SJ, Ständer S. Measuring patient-relevant benefits in pruritus treatment: development and validation of a specific outcomes tool. Br J Dermatol 2009; 161: 1143-1148.
9. FDA Food and Drug Administration. Guidance for industry. Patient-reportedoutcome measures: use in medical product development to support labeling claims. 2009 [cited 2012 Jun 22]. Available from: http://www.ispor.org/workpaper/FDA%20PRO%20Guidance.pdf.
10. EMEA EuropeanMedicinesAgency (2005). Committee for medicinal products for human use (CHMP). Refection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005 [cited 2012 Jun 22]. Available from: http://www.emea.europa.eu/pdfs/human/ewp/13939104en.pdf.
11. Weisshaar E, Gieler U, Kupfer J, Furue M, Saeki H, Yosipovitch G. Questionnaires to assess chronic itch: a consensus paper of the special interest group of the international forum on the study of itch. Acta Derm Venereol 2012; 92: 493-496.
12. Reich A, Halupczok J, Ramus M, Ständer S, Szepietowski J. New data on the validation of VAS and NRS in pruritus assessment: minimal clinically important difference and itch frequency measurement. Acta Derm Venereol 2011; 91: 636.
13. Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D-itch scale: a new measure of pruritus. Br J Dermatol 2010; 162: 587-593.
14. Finlay A, khan G. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
15. Schneider G, Driesch G, Heuft G, Evers S, Luger TA, Stän-der S. Psychosomatic cofactors and psychiatric co morbidity in patients with chronic itch. Clin Exp Dermatol 2006; 31: 762-767.
16. Tessari G, Dalle Vedove C, Loschiavo C, Tessitore N, Rugiu C, Lupo A, et al. The impact of pruritus on the quality of life of patients undergoing dialysis: a single centre cohort study. J Nephrol 2009; 22: 241-248.
17. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-483.
18. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51: 1171-1178.
19. Reich A, Hrehorów E, Szepietowski JC. Pruritus is an important factor negatively infuencing the well-being of psoriatic patients. Acta Derm Venereol 2010; 90: 257-263.
20. Twiss J, Meads DM, Preston EP, Crawford SR, Mckenna SP. Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or a topic dermatitis? J Invest Dermatol 2012; 132: 76-84.
21. Desai NS, Poindexter GB, Miller Monthrop Y, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol 2008; 259: 234-244.
22. krause K, kessler B, Weller K, Veidt J, Chen SC, Martus P, et al. The German version of ItchyQoL: factor analysis, validation and clinical findings. Acta Derm Venereol 2013; 93: 562-568.
23. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
24. Beck AT, Ward CH, Mendelson M, Mock JE, Erbaugh JK. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 6-9.
25. Hamilton M. A rating scale for depression. Neurol Neuro-surg Psychiatry 1960; 23: 56-62.
26. Chrostowska-Plak D, Salomon J, Reich A, Szepietowski JC. Clinical aspects of itch in adult atopic dermatitis patients. Acta Derm Venereol 2009; 89: 379-383.
27. Stores G, Burrows A, Crawford C. Physiological sleep disturbance in children with atopic dermatitis: a case control study. Pediatr Dermatol 1998; 15: 264-268.
28. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992; 15: 376-381.
29. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. The diagnostic validity of the Athens Insomnia Scale. J Psychosom Res 2003; 55: 263-267.
30. Pfab F, Valet M, Napadow V, Tölle TR, Behrendt H, Ring J, et al. Itch and the brain. Chem Immunol Allergy 2012; 98: 253-265.